AstraZeneca agrees to invest $50 billion in US manufacturing and R&D to lower drug prices

svd.se (Swedish)

AstraZeneca has reached an agreement with the White House to lower drug prices in the US. The deal includes AstraZeneca investing $50 billion in US manufacturing and R&D. President Trump is expected to announce the proposal later today. This agreement aligns with Trump's long-standing pledge to reduce pharmaceutical costs for Americans.


With a significance score of 5.6, this news ranks in the top 0.5% of today's 30556 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


AstraZeneca agrees to invest $50 billion in US manufacturing and R&D to lower drug prices | News Minimalist